Researchers at Massachusetts General Hospital discovered that an immune protein, RELMY, can damage heart cells after a heart attack, triggering deadly arrhythmias. In mice, blocking this protein reduced sudden cardiac death twelvefold. Human counterparts show similar patterns, opening new possibilities for therapies that target immune responses to protect the heart post-attack.